Novel diazaspiroalkanes and their use for treatment of CCR8 mediated diseases

Details for Australian Patent Application No. 2004284028 (hide)

Owner AstraZeneca AB

Inventors Dyke, Hazel Joan; Van Den Heuvel, Marco; Price, Stephen; Connolly, Stephen; Bladh, Hakan; Lisius, Annea; Shamovsky, Igor

Agent Freehills

Pub. Number AU-B-2004284028

PCT Pub. Number WO2005/040167

Priority 0302811-5 23.10.03 SE

Filing date 21 October 2004

Wipo publication date 6 May 2005

Acceptance publication date 6 March 2008

International Classifications

C07D 471/10 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

Event Publications

27 April 2006 PCT application entered the National Phase

  PCT publication WO2005/040167 Priority application(s): WO2005/040167

6 March 2008 Application Accepted

  Published as AU-B-2004284028

3 July 2008 Standard Patent Sealed

20 May 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004284030-Acylurea connected and sulfonylurea connected hydroxamates

2004284024-Method for synthesis of acrylamide derivatives